Abstract:Abstract Background: Prostate cancer (PCa) is currently the most commonly diagnosed type of cancer. The incidence and mortality of PCa worldwide correlate with increasing age and bad dietary habits. Previously, we investigated the mRNA/miRNA role on PCa development and progression using high fat diet (HFD) chronically fed mice models. Here our main goal was to investigate the effect of HFD on the expression of prostate cancer-related miRNAs and their relevance in PCa patients. Methods: Using microarray data from mice prostate tumors generated by TRAMP-C1 cell inoculation, we focused on the role of three candidate miRNAs (miR-133a-3p/133b/1-3p) and their target genes. Based on data from public databases, we examined the expression levels of hsa-miR-133a-3p/133b/1-3p and their correlation with clinicopathological features in PCa patients. The biological roles of hsa-miR-133a-3p/133b/1-3p and their relevant target genes were investigated by bioinformatics approaches. The promoter methylation of hsa-miR-133a-3p/133b/1-3p host genes and their correlation with mature miRNA expression was further evaluated. Results: We identified 6 up- and 18 down-regulated miRNAs in TRAMP-C1 mice prostate tumors under HFD conditions using miRNA microarrays. Target genes (1,278) of down-regulated miRNAs involved in cancer-related biological processes were identified using DIANA-TarBase and STRING databases. Three down-regulated miRNAs: hsa-miR-133a-3p, 133b and 1a-3p showed nine common target genes that negatively correlated with miRNA expression in prostate tumors from patients. Hsa-miR-133a-3p/133b/1-3p expression levels were significantly decreased in PCa compared to normal tissues and their low expression correlated with bad clinicopathological features in patients. We also examined the promoter region of hsa-miR-133a-3p/133b/1-3p encoding genes in PCa patients and then compared methylation at these loci with mature miRNA expression. This analysis revealed that hsa-miR-1-2/miR-133a-1 cluster promoter hypermethylation decreased hsa-miR-133a-3p/1-3p expression in prostate tumors. Furthermore, CENPF and WHSC1 , two common hsa-miR-133a-3p/133b/1-3p target genes, were found significantly up-regulated in PCa and positively correlated with advanced clinicopathological characteristics in PCa patients. Conclusion: Our results provide an explanation for the aggressiveness of PCa and link it mechanistically to the attenuation of hsa-miR-133a-3p/133b/1-3p expression by promoter hypermethylation. Hsa-miR-133a-3p/133b/1-3p downregulation may enhance PCa aggressiveness in part by targeting CENPF and WHSC1 . Therefore, hsa-miR-133a-3p/133b/1-3p might be potential therapeutic targets for lethal PCa.

Tumoral periprostatic adipose tissue exovesicles-derived miR-20a-5p regulates prostate cancer cell proliferation and inflammation through the RORA gene

In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs

Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes

Adipose Tissue-Derived Extracellular Vesicles Contribute to Phenotypic Plasticity of Prostate Cancer Cells

Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.

Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer

Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue

Extracellular Vesicles from Human Advanced-Stage Prostate Cancer Cells Modify the Inflammatory Response of Microenvironment-Residing Cells

miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4 and CHORDC1

MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.

miR-593-3p Promotes Proliferation and Invasion in Prostate Cancer Cells by Targeting ADIPOR1

Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer

The PP2A regulator IER5L supports prostate cancer progression

The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell's metabolic crosstalk

Hsa-miR-1-2/miR-133a-1 Cluster Expression Silencing by DNA Hypermethylation Triggers Oncogenes Contributing to Prostate Cancer Aggressiveness

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution

Tumor‐associated macrophages promote prostate cancer progression via exosome‐mediated miR‐95 transfer

Modulation of the pre-metastatic bone niche: molecular changes mediated by bone-homing prostate cancer extracellular vesicles

Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling Through Critical Pathways to Regulate Cell Viability in Prostate Cancer

Proangiogenic potential of plasma exosomes from prostate cancer patients

miR-92a-1-5p enriched prostate cancer extracellular vesicles regulate osteoclast function via MAPK1 and FoxO1